Diaceutics PLC (AIM:DXRX)

Market Cap	108.68M
Revenue (ttm)	34.40M
Net Income (ttm)	-1.52M
Shares Out	84.91M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	49.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,159
Average Volume	69,181
Open	125.30
Previous Close	126.50
Day's Range	125.30 - 128.00
52-Week Range	106.00 - 168.00
Beta	0.95
RSI	23.14
Earnings Date	Dec 24, 2025

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 199
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DXRX

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.